SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019071
Filing Date
2022-05-10
Accepted
2022-05-10 07:17:39
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-10q_20220331.htm   iXBRL 10-Q 1675707
2 EX-10.14 pmvp-ex1014_46.htm EX-10.14 46809
3 EX-31.1 pmvp-ex311_6.htm EX-31.1 19915
4 EX-31.2 pmvp-ex312_7.htm EX-31.2 20472
5 EX-32.1 pmvp-ex321_8.htm EX-32.1 9622
6 EX-32.2 pmvp-ex322_9.htm EX-32.2 9850
  Complete submission text file 0001564590-22-019071.txt   6236542

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20220331.xsd EX-101.SCH 42835
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmvp-20220331_cal.xml EX-101.CAL 42179
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmvp-20220331_def.xml EX-101.DEF 79126
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20220331_lab.xml EX-101.LAB 319968
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20220331_pre.xml EX-101.PRE 229682
55 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-10q_20220331_htm.xml XML 1176751
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 22907348
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences